Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1973 1
1975 1
1976 1
1977 1
1979 1
1987 1
1989 1
1991 1
1994 1
1995 1
1996 1
1998 3
1999 2
2000 2
2001 1
2002 3
2003 2
2004 2
2005 4
2006 9
2007 17
2008 22
2009 31
2010 41
2011 46
2012 72
2013 55
2014 68
2015 76
2016 77
2017 70
2018 79
2019 100
2020 126
2021 132
2022 120
2023 90
2024 49

Text availability

Article attribute

Article type

Publication date

Search Results

1,126 results

Results by year

Filters applied: . Clear all
Page 1
Neuromyelitis optica spectrum disorders.
Huda S, Whittam D, Bhojak M, Chamberlain J, Noonan C, Jacob A. Huda S, et al. Clin Med (Lond). 2019 Mar;19(2):169-176. doi: 10.7861/clinmedicine.19-2-169. Clin Med (Lond). 2019. PMID: 30872305 Free PMC article. Review.
Neuromyelitis optica spectrum disorder (NMOSD) is an uncommon antibody-mediated disease of the central nervous system. ...Relapse prevention is crucial and achieved with long-term immunosuppression. In this article we review the pathogenesis, clinical feature …
Neuromyelitis optica spectrum disorder (NMOSD) is an uncommon antibody-mediated disease of the central nervous system. ...Rela …
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
Kümpfel T, Giglhuber K, Aktas O, Ayzenberg I, Bellmann-Strobl J, Häußler V, Havla J, Hellwig K, Hümmert MW, Jarius S, Kleiter I, Klotz L, Krumbholz M, Paul F, Ringelstein M, Ruprecht K, Senel M, Stellmann JP, Bergh FT, Trebst C, Tumani H, Warnke C, Wildemann B, Berthele A; Neuromyelitis Optica Study Group (NEMOS). Kümpfel T, et al. J Neurol. 2024 Jan;271(1):141-176. doi: 10.1007/s00415-023-11910-z. Epub 2023 Sep 7. J Neurol. 2024. PMID: 37676297 Free PMC article. Review.
This manuscript presents practical recommendations for managing acute attacks and implementing preventive immunotherapies for neuromyelitis optica spectrum disorders (NMOSD), a rare autoimmune disease that causes severe inflammation in the central nervous system (CN …
This manuscript presents practical recommendations for managing acute attacks and implementing preventive immunotherapies for neuromyelit …
Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies.
Carnero Contentti E, Correale J. Carnero Contentti E, et al. J Neuroinflammation. 2021 Sep 16;18(1):208. doi: 10.1186/s12974-021-02249-1. J Neuroinflammation. 2021. PMID: 34530847 Free PMC article. Review.
Neuromyelitis optica (NMO) is a chronic inflammatory autoimmune disease of the central nervous system (CNS) characterized by acute optic neuritis (ON) and transverse myelitis (TM). ...In light of the new evidence on NMOSD pathophysiology and of preliminary results f …
Neuromyelitis optica (NMO) is a chronic inflammatory autoimmune disease of the central nervous system (CNS) characterized by a …
Neuromyelitis optica.
Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B. Jarius S, et al. Nat Rev Dis Primers. 2020 Oct 22;6(1):85. doi: 10.1038/s41572-020-0214-9. Nat Rev Dis Primers. 2020. PMID: 33093467 Review.
Neuromyelitis optica (NMO; also known as Devic syndrome) is a clinical syndrome characterized by attacks of acute optic neuritis and transverse myelitis. ...NMO was previously associated with a poor prognosis; however, treatment with steroids and plasma excha …
Neuromyelitis optica (NMO; also known as Devic syndrome) is a clinical syndrome characterized by attacks of acute optic …
Adverse Events in NMOSD Therapy.
Giglhuber K, Berthele A. Giglhuber K, et al. Int J Mol Sci. 2022 Apr 9;23(8):4154. doi: 10.3390/ijms23084154. Int J Mol Sci. 2022. PMID: 35456972 Free PMC article. Review.
Neuromyelitis optica spectrum disorders (NMOSD) are rare neurologic autoimmune diseases that have a poor prognosis if left untreated. ...
Neuromyelitis optica spectrum disorders (NMOSD) are rare neurologic autoimmune diseases that have a poor prognosis if left unt …
Neuromyelitis Optica Spectrum Disorders.
Costello F. Costello F. Continuum (Minneap Minn). 2022 Aug 1;28(4):1131-1170. doi: 10.1212/CON.0000000000001168. Continuum (Minneap Minn). 2022. PMID: 35938660 Review.
PURPOSE OF REVIEW: This article reviews the cardinal clinical features, distinct immunopathology, current diagnostic criteria, relapse-related risk factors, emerging biomarkers, and evolving treatment strategies pertaining to neuromyelitis optica spectrum dis …
PURPOSE OF REVIEW: This article reviews the cardinal clinical features, distinct immunopathology, current diagnostic criteria, relaps …
Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment.
Bennett JL, Costello F, Chen JJ, Petzold A, Biousse V, Newman NJ, Galetta SL. Bennett JL, et al. Lancet Neurol. 2023 Jan;22(1):89-100. doi: 10.1016/S1474-4422(22)00187-9. Epub 2022 Sep 22. Lancet Neurol. 2023. PMID: 36155661 Review.
Optic neuritis is an inflammatory optic neuropathy that is commonly indicative of autoimmune neurological disorders including multiple sclerosis, myelin-oligodendrocyte glycoprotein antibody-associated disease, and neuromyelitis optica spectrum disorder. Early cl …
Optic neuritis is an inflammatory optic neuropathy that is commonly indicative of autoimmune neurological disorders including multiple scler …
Neurological update: MOG antibody disease.
Wynford-Thomas R, Jacob A, Tomassini V. Wynford-Thomas R, et al. J Neurol. 2019 May;266(5):1280-1286. doi: 10.1007/s00415-018-9122-2. Epub 2018 Dec 19. J Neurol. 2019. PMID: 30569382 Free PMC article. Review.
To avoid misdiagnosis, MOG antibody testing should be undertaken in selected cases presenting clinical and paraclinical features that are felt to be in keeping with MOG-AD, using a validated cell-based assay. MRI characteristics can help in differentiating MOG-AD from othe …
To avoid misdiagnosis, MOG antibody testing should be undertaken in selected cases presenting clinical and paraclinical features that …
New therapies for neuromyelitis optica spectrum disorder.
Levy M, Fujihara K, Palace J. Levy M, et al. Lancet Neurol. 2021 Jan;20(1):60-67. doi: 10.1016/S1474-4422(20)30392-6. Epub 2020 Nov 10. Lancet Neurol. 2021. PMID: 33186537 Review.
BACKGROUND: Neuromyelitis optica spectrum disorder is an autoimmune disease of the CNS that primarily affects the optic nerves and spinal cord. ...WHERE NEXT?: Despite the rarity of neuromyelitis optica spectrum disorder, a relative abundance of preven …
BACKGROUND: Neuromyelitis optica spectrum disorder is an autoimmune disease of the CNS that primarily affects the optic nerves …
Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD.
Redenbaugh V, Flanagan EP. Redenbaugh V, et al. Neurotherapeutics. 2022 Apr;19(3):808-822. doi: 10.1007/s13311-022-01206-x. Epub 2022 Mar 10. Neurotherapeutics. 2022. PMID: 35267170 Free PMC article. Review.
Aquaporin-4 (AQP4)-IgG seropositive neuromyelitis optica spectrum disorders (AQP4-IgG seropositive NMOSD) and myelin oligodendrocyte glycoprotein (MOG)-IgG-associated disease (MOGAD) are inflammatory demyelinating disorders distinct from each other and from multiple …
Aquaporin-4 (AQP4)-IgG seropositive neuromyelitis optica spectrum disorders (AQP4-IgG seropositive NMOSD) and myelin oligodend …
1,126 results